Unique ID issued by UMIN | UMIN000059035 |
---|---|
Receipt number | R000067474 |
Scientific Title | A study on the effects of long-term hydrogen jelly intake on health |
Date of disclosure of the study information | 2025/09/09 |
Last modified on | 2025/09/09 14:43:41 |
A study on the effects of long-term hydrogen jelly intake on health
A study on the effects of long-term hydrogen jelly intake on health
A study on the effects of long-term hydrogen jelly intake on health
A study on the effects of long-term hydrogen jelly intake on health
Japan |
N/A
Adult |
Others
NO
The purpose of this study is to examine the effect of long-term intake of hydrogen jelly on improving biological rhythms.
Efficacy
Changes in heart rate variability data before and after intervention (after 9 weeks)
Changes in heart rate variability data before and after intervention (after 5 weeks), Patient Health Questionnaire-9 (PHQ-9), Pittsburgh Sleep Quality Index, new version of the STAI State-Trait Anxiety Inventory, DLQI questionnaire, SKINDEX29 questionnaire, VOCs at rest, stratum corneum moisture content, and transepidermal water loss before and after intervention (after 5 and 9 weeks)
Interventional
Parallel
Non-randomized
Open -no one is blinded
Dose comparison
2
Prevention
Food |
Take one bottle of hydrogen jelly per day for two months.
Take three bottles of hydrogen jelly per day for two months.
20 | years-old | <= |
60 | years-old | >= |
Male and Female
1. Healthy individuals between the ages of 20 and 60.
2. Individuals who drink alcohol regularly (at least three times a week, 10g per session (equivalent to 350ml of beer)).
3. Individuals with mild skin symptoms (a score of 2 or higher on the DLQI questionnaire).
4. Individuals who fully understand the purpose of this study and agree to participate in it.
1. Individuals who the principal investigator or co-investigator deems inappropriate for this study.
2. Individuals diagnosed with lifestyle-related disease #2 at the time of participation and receiving oral medication.
3. Individuals receiving oral medication for cerebrovascular, cardiovascular, pulmonary, digestive, renal, or autoimmune diseases at the time of participation.
4. Individuals who have used hydrogen products within the past week at the time of consent.
5. Individuals who plan to use hydrogen products after consenting until the end of the study.
6. Individuals with dementia or psychiatric disorders who are unable to understand the significance of this study.
30
1st name | Katsumata |
Middle name | |
Last name | Yoshinori |
Keio University
School of Medicine, Institute for Integrated Sports Medicine
160-0016
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 Japan
03-5269-9054
goodcentury21@keio.jp
1st name | Katsumata |
Middle name | |
Last name | Yoshinori |
Keio University
School of Medicine, Institute for Integrated Sports Medicine
160-0016
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 Japan
03-5269-9054
goodcentury21@keio.jp
Keio University
Shinryo Corporation
Other
Keio University School of Medicine
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 Japan
03-5363-3503
med-rinri-jimu@adst.keio.ac.jp
NO
2025 | Year | 09 | Month | 09 | Day |
Unpublished
Preinitiation
2025 | Year | 08 | Month | 29 | Day |
2025 | Year | 10 | Month | 01 | Day |
2030 | Year | 03 | Month | 31 | Day |
2025 | Year | 09 | Month | 09 | Day |
2025 | Year | 09 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067474